EC Number | Application | Comment | Organism |
---|---|---|---|
3.2.1.52 | medicine | enzyme enhancement therapy utilizing small molecules as pharmacological chaperones is a promising therapeutic approach to treat late-onset forms of Tay-Sachs disease and Sandhoff disease, as well as other lysosomal storage diseases | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.2.1.52 | (1E)-2-nitro-1H-indene-1,3(2H)-dione oxime | - |
Homo sapiens | |
3.2.1.52 | 2,2'-(iminodiethane-2,1-diyl)bis(1H-benzo[de]isoquinoline-1,3(2H)-dione) | - |
Homo sapiens | |
3.2.1.52 | 2-(4-chlorobenzyl)-5-methyl-2,6-dihydro-1H-pyrrolo[3,4-d]pyridazin-1-one | - |
Homo sapiens | |
3.2.1.52 | 2-amino-6-(methoxymethyl)pyrimidin-4-ol | - |
Homo sapiens | |
3.2.1.52 | elinafide | - |
Homo sapiens | |
3.2.1.52 | N-acetylglucosamine thiazoline | - |
Homo sapiens | |
3.2.1.52 | pyrimethamine | - |
Homo sapiens | |
3.2.1.52 | thioguanine | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.2.1.52 | additional information | Homo sapiens | mutations in the evolutionarily related HEXA or HEXB genes, which encode the alpha- or beta-subunits of heterodimeric beta-hexosaminidase A, are associated with Tay-Sachs or Sandhoff disease, respectively. The majority of HEXA and HEXB mutations prevent any Hex A from being formed and result in the infantile/acute form of Tay-Sachs (ITSD) or Sandhoff (ISD) disease. These are devastating neurodegenerative diseases that result in death by the age of 4 years | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.2.1.52 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.2.1.52 | 4-methylumbelliferyl beta-N-acetylglucosamine + H2O | - |
Homo sapiens | ? | - |
? | |
3.2.1.52 | additional information | mutations in the evolutionarily related HEXA or HEXB genes, which encode the alpha- or beta-subunits of heterodimeric beta-hexosaminidase A, are associated with Tay-Sachs or Sandhoff disease, respectively. The majority of HEXA and HEXB mutations prevent any Hex A from being formed and result in the infantile/acute form of Tay-Sachs (ITSD) or Sandhoff (ISD) disease. These are devastating neurodegenerative diseases that result in death by the age of 4 years | Homo sapiens | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.2.1.52 | beta-hexosaminidase | - |
Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.2.1.52 | 0.0008 | - |
2,2'-(iminodiethane-2,1-diyl)bis(1H-benzo[de]isoquinoline-1,3(2H)-dione) | - |
Homo sapiens | |
3.2.1.52 | 0.0061 | - |
(1E)-2-nitro-1H-indene-1,3(2H)-dione oxime | - |
Homo sapiens | |
3.2.1.52 | 0.0061 | - |
N-acetylglucosamine thiazoline | - |
Homo sapiens | |
3.2.1.52 | 0.013 | - |
pyrimethamine | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.2.1.52 | 0.008 | - |
- |
Homo sapiens | pyrimethamine | |
3.2.1.52 | 0.025 | - |
- |
Homo sapiens | 2-amino-6-(methoxymethyl)pyrimidin-4-ol | |
3.2.1.52 | 0.042 | - |
- |
Homo sapiens | elinafide | |
3.2.1.52 | 0.13 | - |
- |
Homo sapiens | thioguanine | |
3.2.1.52 | 6 | - |
- |
Homo sapiens | 2,2'-(iminodiethane-2,1-diyl)bis(1H-benzo[de]isoquinoline-1,3(2H)-dione) | |
3.2.1.52 | 27 | - |
- |
Homo sapiens | (1E)-2-nitro-1H-indene-1,3(2H)-dione oxime | |
3.2.1.52 | 29 | - |
- |
Homo sapiens | 2-(4-chlorobenzyl)-5-methyl-2,6-dihydro-1H-pyrrolo[3,4-d]pyridazin-1-one |